Summit Medical has announced a partnership with the World Health Organization, pledging to provide medical cannabis for a “medical marijuana patient group” to be formed in South Africa.
The announcement came as the South African government announced the launch of a national investigation into the company’s activities.
Under the terms of the agreement, Summit Medical is allowed to operate under the umbrella of the World Medical Association and will be allowed to work on the same issues as other medical marijuana companies, according to a statement.
“We are committed to working with the Government of South Africa to address the challenges associated with the illegal sale and distribution of cannabis, and we intend to build a business model that meets the needs of patients and their caregivers in South African communities,” Summit Medical said in the statement.
“The new company will be dedicated to providing compassionate and compassionate access to cannabis to those who need it most.”
In an earlier statement, Summit Medic said the company is currently “operating as an independent medical marijuana company.”
The statement did not specifically name South Africa, but South Africa is one of a number of countries where medical cannabis companies are operating.
The United States has been one of the most aggressive, and has approved the use of cannabis for treating some types of post-traumatic stress disorder and cancer, and it has had to regulate the sale of marijuana for that purpose.
The announcement comes as South Africa has grappled with its own opioid crisis, and is one the few African nations where cannabis is legal for recreational use.
South Africa already has the highest overdose death rate in the world.
South Africa’s drug crisis, however, has not yet reached the extent of the opioid crisis.
In October, South Africa’s Health Minister Nelson Mandela announced that South Africa would be one of five countries in the entire world where cannabis will be decriminalized and regulated as a medicine.